MedTrace Logo

An International Survey on Aminoglycoside Practices in Critically Ill Patients: AMINO III Survey

NCT02850029 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 964

Last updated 2025-11-21

No results posted yet for this study

Summary

This is an international observational cohort study on current aminoglycoside practices in intensive care units. Clinical and demographic data, dosing and therapeutic drug monitoring data will be collected during the first week of aminoglycoside (tobramycin, amikacin or gentamicin) administration in different countries over a year. A minimum of ten consecutive patients will be enrolled at each site.

Conditions

  • Underdosing of Aminoglycosides
  • Critical Illness

Interventions

OTHER

Observational study, no intervention

Sponsors & Collaborators

  • Centre Hospitalier Universitaire de Nīmes

    lead OTHER

Principal Investigators

  • Claire Roger, MD · Centre Hospitalier Universitaire de Nîmes

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-05-21
Primary Completion
2017-12-31
Completion
2017-12-31

Countries

  • Australia
  • Chile
  • France
  • Greece
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02850029 on ClinicalTrials.gov